Latest Articles

Between The Lines: GVHD, Episode 1 – Understanding the Foundation of Graft vs Host Disease

Tandem Meetings Transplantation and Cellular Therapy Meetings of ASTCT® and CIBMTR®

The Congress Connection: cGvHD and Transplant Key Takeaways in 2025

IL-4 and IL-13 are key and central cytokines with unique and overlapping roles contributing to the pathophysiology of CRSwNP

Consensus Guidance for Monitoring Children with Islet Autoantibody-Positive Pre-Stage 3 Autoimmune Type 1 Diabetes (T1D)

Considerations for bullous pemphigoid management

The management of bullous pemphigoid is challenging and new treatment approaches are needed. Read this article to find out more.

What is Bullous Pemphigoid

The heterogeneous presentation of bullous pemphigoid may shed light on why patients are underdiagnosed. Read the article to learn more

Treatments and challenges for bullous pemphigoid

Systemic corticosteroids and other immunosuppressants are the current mainstay of therapy but carry risks for patients with bullous pemphigoid. Read this article to find out more

Future of ITP

Pathophysiology of Bullous Pemphigoid

In bullous pemphigoid, autoimmunity to BP180 and BP230 is thought to trigger a type 2 inflammatory response. Read this article to find out more